Research ArticleOpen AccessGoogle Scholar indexed
Therapy for <i>H.</i> <i>pylori</i>: Current concepts
Department of Clinical and Surgical Science, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
Gastroenterology and Digestive Endoscopy, “Nuovo Regina Margherita” Hospital, Rome, Italy
Department of Clinical and Surgical Science, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
Gastroenterology Unit, University of Brescia, Brescia, Italy
Department of Clinical and Surgical Science, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
Department of Clinical and Surgical Science, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
Department of Clinical and Surgical Science, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
Department of Internal Medicine, Aging and Kidney Disease, Alma Mater Studiorum, University of Bologna, Bologna, Italy
Department of Internal Medicine, Aging and Kidney Disease, Alma Mater Studiorum, University of Bologna, Bologna, Italy
Department of Clinical and Surgical Science, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
- 1 Department of Clinical and Surgical Science, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
- 2 Gastroenterology and Digestive Endoscopy, “Nuovo Regina Margherita” Hospital, Rome, Italy
- 3 Department of Clinical and Surgical Science, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
- 4 Gastroenterology Unit, University of Brescia, Brescia, Italy
- 5 Department of Clinical and Surgical Science, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
- 6 Department of Clinical and Surgical Science, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
- 7 Department of Clinical and Surgical Science, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
- 8 Department of Internal Medicine, Aging and Kidney Disease, Alma Mater Studiorum, University of Bologna, Bologna, Italy
- 9 Department of Internal Medicine, Aging and Kidney Disease, Alma Mater Studiorum, University of Bologna, Bologna, Italy
- 10 Department of Clinical and Surgical Science, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy
Open Journal of Gastroenterology·Volume 03 (2013)·Pages 38–41·Published 21 February 2013·DOI10.4236/ojgas.2013.31006
Copy link · social · email
Abstract
Helicobacter pylori plays an important role in the pathogenesis of chronic active gastritis, peptic ulcer and gastric mucosa-associated lymphoid tissue-lymphoma, and is also involved in carcinogenesis of the stomach. Since now no current first-line therapy is able to cure the infection in all treated patients. We evaluated data on the most successful therapy regimens—sequential, concomitant and quadruple thera pies—and on the standard therapy available for H. pylori eradication. When therapy fails several factors may be involved: we reviewed both bacterial and host factors that can affect the eradication and that can be involved in therapeutic management of the H. pylori infection.
Keywords<i>Helicobacter</i><i>pylori</i>Sequential TherapyEradication
- Vakil, N. and Megraud, F. (2007) Eradication treatment for Helicobacter pylori. Gastroenterology, 133, 985-1001. doi:10.1053/j.gastro.2007.07.008
- Ford, AC., Delaney, BC., Forman, D. et al. (2004) Eradication therapy in Helicobacter pylori positive peptic ulcer disease: Systematic review and economic analysis. American Journal of Gastroenterology, 99, 1833-1855. doi:10.1111/j.1572-0241.2004.40014.x
- Chen, L.T., Lin, J.T., Tai, J.J., et al. (2005) Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high grade transformed MALT lymphoma. Journal of the National Cancer Institute, 97, 1345-1353. doi:10.1093/jnci/dji277
- Morgner, A., Bayerdorff, E., Neubauer, A., et al. (2000) Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori. Gastroenterology Clinics of North America, 29, 593 607. doi:10.1016/S0889-8553(05)70132-1
- Malfertheiner, P., Sipponen, P., Naumann, M., et al. (2005) Helicobacter pylori eradication has the potential to prevent gastric cancer: A state-of-the-art critique. American Journal of Gastroenterology, 100, 2100-2115. doi:10.1111/j.1572-0241.2005.41688.x
- Stasi, R., Sarpatwari, A., Segal, J.B., et al. (2009) Effects of Helicobacter pylori eradication in patients with immune thrombocytopenic purpura: A systematic review. Blood, 113, 1231-1240. doi:10.1182/blood-2008-07-167155
- Huang, X., Qu, X., Yan, W., et al. (2010) Iron deficiency anemia can be improved after eradication of Helicobacter pylori. Postgraduate Medical Journal, 86, 272-278. doi:10.1136/pgmj.2009.089987
- Malfertheiner, P., Megraud, F., O’Morain, C., et al. (2012) Current concepts in the Management of Helicobacter pylori infection: The Maastricht IV/Florence Consensus Report. Gut, 61, 646-664. doi:10.1136/gutjnl-2012-302084
- Fock, K.M., Katelaris, P., Sugano, K., et al. (2009) Second Asia-Pacific consensus guidelines for Helicobacter pylori infection. Journal of Gastroenterology and Hepatology, 24, 1587-600.
- Gisbert, J.P. (2010) Sequential or concomitant therapy for Helicobacter pylori eradication? Journal of Clinical Gastroenterology, 44, 313-325.
- Zagari, R.M., Bianchi-Porro, G., et al. (2007) Comparison of one and two weeks of Omeprazole, amoxicillin and Clarithromycin treatment for Helicobacter pylori eradication: The HYPER study. Gut, 56, 475-479. doi:10.1136/gut.2006.102269
- Paoluzi, P., Iacopini, F., Crispino, P., et al. (2006) 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: A large prospective single-center randomized study. Helicobacter, 11, 562-568. doi:10.1111/j.1523-5378.2006.00459.x